Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
5-Aminovaleric acid, also known as Delta-Amino Valeric Acid, is a delta-amino acid and an omega-amino fatty acid. It is a methylene homologue of gamma-aminobutyric acid (GABA) and functions as a weak GABA agonist. This compound is a human and microbial metabolite, found in the gut and in human saliva, with elevated concentrations observed in patients with chronic periodontitis. Additionally, it is recognized as an antifibrinolytic amino acid analog, acting as a weak inhibitor of the blood clotting pathway. It has been listed in pharmaceutical databases like DrugBank and ZINC15.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on 5-Aminovaleric acid.